Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Monica L. Acevedo"'
Autor:
Fabian Figueroa, Alonso Vega-Gibson, Joseline Catrileo, Aracelly Gaete-Argel, Sebastian Riquelme-Barrios, Luis Antonio Alonso-Palomares, Lorena I. Tapia, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Monica L. Acevedo
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
N6-methyladenosine (m6A) is the most abundant internal modification described in eukaryotic mRNA and several viral RNA including human respiratory syncytial virus (HRSV). Here, we evaluated the impact of m6A writers, erasers and readers on HRSV genom
Externí odkaz:
https://doaj.org/article/2ac153e567624efa84e82788b8e79211
Autor:
Fabian, Figueroa, Alonso, Vega-Gibson, Joseline, Catrileo, Aracelly, Gaete-Argel, Sebastian, Riquelme-Barrios, Luis Antonio, Alonso-Palomares, Lorena I, Tapia, Fernando, Valiente-Echeverría, Ricardo, Soto-Rifo, Monica L, Acevedo
Publikováno v:
Frontiers in Cell and Developmental Biology
N6-methyladenosine (m6A) is the most abundant internal modification described in eukaryotic mRNA and several viral RNA including human respiratory syncytial virus (HRSV). Here, we evaluated the impact of m6A writers, erasers and readers on HRSV genom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cae4be844d2704e10f4bf658bd8313f2
https://pubmed.ncbi.nlm.nih.gov/34671602
https://pubmed.ncbi.nlm.nih.gov/34671602
Autor:
Daniela Rivera-Pérez, Constanza Méndez, Benjamín Diethelm-Varela, Felipe Melo-González, Yaneisi Vázquez, Xing Meng, Qianqian Xin, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramirez, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Patricio Astudillo, Nicole Le Corre, Katia Abarca, Cecilia Perret, Pablo A. González, Jorge A. Soto, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundVaccine effectiveness against SARS-CoV-2 infection has been somewhat limited due to the widespread dissemination of the Omicron variant, its subvariants, and the immune response dynamics of the naturally infected with the virus.MethodsTwelv
Externí odkaz:
https://doaj.org/article/7c001b5b42b5457faed5b3a10f22f0e2
Autor:
Leonardo Vargas, Nicolás Valdivieso, Fabián Tempio, Valeska Simon, Daniela Sauma, Lucía Valenzuela, Caroll Beltrán, Loriana Castillo-Delgado, Ximena Contreras-Benavides, Mónica L. Acevedo, Johanna Acevedo, Rafael I. Gonzalez, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Mario Rosemblatt, Mercedes Lopez, Fabiola Osorio, María Rosa Bono
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background Chile was severely affected by COVID19 outbreaks but was also one of the first countries to start a nationwide program to vaccinate against the disease. Furthermore, Chile became one of the fastest countries to inoculate a high pe
Externí odkaz:
https://doaj.org/article/6b8f00289e5c4eaabb376b33a3001598
Autor:
Aracelly Gaete-Argel, Vicente Saavedra-Alarcón, Denis Sauré, Luis Alonso-Palomares, Mónica L. Acevedo, Marion Alarcón, Susan M. Bueno, Alexis M. Kalergis, Ricardo Soto-Rifo, Fernando Valiente-Echeverría, Claudia P. Cortes
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionBooster doses of SARS-CoV-2 vaccines improve seroconversion rates in solid organ transplant recipients (SOTRs) but the impact of homologous and heterologous booster doses in neutralizing antibody (NAb) titers and their ability to interfer
Externí odkaz:
https://doaj.org/article/72f56cbebb094dc19df8a6b1e11c4057
Autor:
Jorge A. Soto, Felipe Melo-González, Cristián Gutierrez-Vera, Bárbara M. Schultz, Roslye V. Berríos-Rojas, Daniela Rivera-Pérez, Alejandro Piña-Iturbe, Guillermo Hoppe-Elsholz, Luisa F. Duarte, Yaneisi Vázquez, Daniela Moreno-Tapia, Mariana Ríos, Pablo A. Palacios, Richard Garcia-Betancourt, Álvaro Santibañez, Gaspar A. Pacheco, Constanza Mendez, Catalina A. Andrade, Pedro H. Silva, Benjamín Diethelm-Varela, Patricio Astudillo, Mario Calvo, Antonio Cárdenas, Marcela González, Macarena Goldsack, Valentina Gutiérrez, Marcela Potin, Andrea Schilling, Lorena I. Tapia, Loreto Twele, Rodolfo Villena, Alba Grifoni, Alessandro Sette, Daniela Weiskopf, Rodrigo A. Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Angello Retamal-Díaz, Nathalia Muñoz-Jofré, Xing Meng, Qianqian Xin, Eduardo Alarcón-Bustamante, José V. González-Aramundiz, Nicole Le Corre, María Javiera Álvarez-Figueroa, Pablo A. González, Katia Abarca, Cecilia Perret, Leandro J. Carreño, Susan M. Bueno, Alexis M. Kalergis
Publikováno v:
mBio, Vol 13, Iss 6 (2022)
ABSTRACT Multiple vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been evaluated in clinical trials. However, trials addressing the immune response in the pediatric population are scarce. The inactivated vaccine Cor
Externí odkaz:
https://doaj.org/article/cf113e0121754f51995644752d348004
Autor:
Bárbara M. Schultz, Felipe Melo-González, Luisa F. Duarte, Nicolás M. S. Gálvez, Gaspar A. Pacheco, Jorge A. Soto, Roslye V. Berríos-Rojas, Liliana A. González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Catalina A. Andrade-Parra, Omar P. Vallejos, Alejandro Piña-Iturbe, Carolina Iturriaga, Marcela Urzua, María S. Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L. Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, José V. González-Aramundiz, Pablo A. González, Katia Abarca, Alexis M. Kalergis, Susan M. Bueno
Publikováno v:
mBio, Vol 13, Iss 4 (2022)
ABSTRACT CoronaVac is an inactivated SARS-CoV-2 vaccine approved by the World Health Organization (WHO). Previous studies reported increased levels of neutralizing antibodies and specific T cells 2 and 4 weeks after two doses of CoronaVac; these leve
Externí odkaz:
https://doaj.org/article/0d12c0aeee20419bb5fc3ab69b554f1b
Autor:
Alejandro Escobar, Felipe E. Reyes-López, Mónica L. Acevedo, Luis Alonso-Palomares, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Hugo Portillo, Jimena Gatica, Ivan Flores, Estefanía Nova-Lamperti, Carlos Barrera-Avalos, María Rosa Bono, Leonardo Vargas, Valeska Simon, Elias Leiva-Salcedo, Cecilia Vial, Juan Hormazabal, Lina Jimena Cortes, Daniel Valdés, Ana M. Sandino, Mónica Imarai, Claudio Acuña-Castillo
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
CoronaVac vaccine from Sinovac Life Science is currently being used in several countries. In Chile, the effectiveness of preventing hospitalization is higher than 80% with a vaccination schedule. However, to date, there are no data about immune respo
Externí odkaz:
https://doaj.org/article/567bda70ec194d8aa689dad8556c9e4f